Life sciences IP management in an age of opportunity

By Peter A Ackerman and Russell L Parr The life sciences industries provide some of the best examples of the risk/reward continuum inherent in the creation and commercialisation of ideas. The risks are considerable given the costs of complex research and development, regulatory requirement, and intellectual property owned by others that must be manoeuvred in order […]